The invention comprises the use of a fibrate and/or the compound Wyeth 14,643 for preparation of a pharmaceutical composition for the prevention and/or treatment of conditions associated with low/decreased bone mineral density (BMD), and/or for increasing the BMD by decreasing the bone resorption.
展开▼
